Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 90

1.

Effects of NR1H3 genetic variation on the expression of liver X receptor α and the progression of Alzheimer's disease.

Natunen T, Martiskainen H, Sarajärvi T, Helisalmi S, Pursiheimo JP, Viswanathan J, Laitinen M, Mäkinen P, Kauppinen T, Rauramaa T, Leinonen V, Alafuzoff I, Haapasalo A, Soininen H, Hiltunen M.

PLoS One. 2013 Nov 20;8(11):e80700. doi: 10.1371/journal.pone.0080700. eCollection 2013.

PMID:
24278306
[PubMed - in process]
Free PMC Article
2.

Genetic analysis of genes involved in amyloid-β degradation and clearance in Alzheimer's disease.

Natunen T, Helisalmi S, Vepsäläinen S, Sarajärvi T, Antikainen L, Mäkinen P, Herukka SK, Koivisto AM, Haapasalo A, Soininen H, Hiltunen M.

J Alzheimers Dis. 2012;28(3):553-9. doi: 10.3233/JAD-2011-111109.

PMID:
22027013
[PubMed - indexed for MEDLINE]
3.

Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease.

Premkumar DR, Cohen DL, Hedera P, Friedland RP, Kalaria RN.

Am J Pathol. 1996 Jun;148(6):2083-95.

PMID:
8669492
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Genetic associations between cathepsin D exon 2 C-->T polymorphism and Alzheimer's disease, and pathological correlations with genotype.

Davidson Y, Gibbons L, Pritchard A, Hardicre J, Wren J, Tian J, Shi J, Stopford C, Julien C, Thompson J, Payton A, Thaker U, Hayes AJ, Iwatsubo T, Pickering-Brown SM, Pendleton N, Horan MA, Burns A, Purandare N, Lendon CL, Neary D, Snowden JS, Mann DM.

J Neurol Neurosurg Psychiatry. 2006 Apr;77(4):515-7.

PMID:
16543533
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Genotype-related differences of hippocampal apolipoprotein E levels only in early stages of neuropathological changes in Alzheimer's disease.

Glöckner F, Meske V, Ohm TG.

Neuroscience. 2002;114(4):1103-14.

PMID:
12379263
[PubMed - indexed for MEDLINE]
6.

Concerted changes in transcripts in the prefrontal cortex precede neuropathology in Alzheimer's disease.

Bossers K, Wirz KT, Meerhoff GF, Essing AH, van Dongen JW, Houba P, Kruse CG, Verhaagen J, Swaab DF.

Brain. 2010 Dec;133(Pt 12):3699-723. doi: 10.1093/brain/awq258. Epub 2010 Oct 1.

PMID:
20889584
[PubMed - indexed for MEDLINE]
Free Article
7.

Interaction between HMGCR and ABCA1 cholesterol-related genes modulates Alzheimer's disease risk.

Rodríguez-Rodríguez E, Mateo I, Infante J, Llorca J, García-Gorostiaga I, Vázquez-Higuera JL, Sánchez-Juan P, Berciano J, Combarros O.

Brain Res. 2009 Jul 14;1280:166-71. doi: 10.1016/j.brainres.2009.05.019. Epub 2009 May 14.

PMID:
19446537
[PubMed - indexed for MEDLINE]
8.

Apolipoprotein C-I is an APOE genotype-dependent suppressor of glial activation.

Cudaback E, Li X, Yang Y, Yoo T, Montine KS, Craft S, Montine TJ, Keene CD.

J Neuroinflammation. 2012 Aug 10;9:192. doi: 10.1186/1742-2094-9-192.

PMID:
22883744
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Rapid progression from mild cognitive impairment to Alzheimer's disease in subjects with elevated levels of tau in cerebrospinal fluid and the APOE epsilon4/epsilon4 genotype.

Blom ES, Giedraitis V, Zetterberg H, Fukumoto H, Blennow K, Hyman BT, Irizarry MC, Wahlund LO, Lannfelt L, Ingelsson M.

Dement Geriatr Cogn Disord. 2009;27(5):458-64. doi: 10.1159/000216841. Epub 2009 May 7.

PMID:
19420940
[PubMed - indexed for MEDLINE]
10.

Oxidative balance in Alzheimer's disease: relationship to APOE, Braak tangle stage, and the concentrations of soluble and insoluble amyloid-β.

Tayler H, Fraser T, Miners JS, Kehoe PG, Love S.

J Alzheimers Dis. 2010;22(4):1363-73. doi: 10.3233/JAD-2010-101368.

PMID:
20930272
[PubMed - indexed for MEDLINE]
11.

Apolipoprotein E and beta-amyloid levels in the hippocampus and frontal cortex of Alzheimer's disease subjects are disease-related and apolipoprotein E genotype dependent.

Beffert U, Cohn JS, Petit-Turcotte C, Tremblay M, Aumont N, Ramassamy C, Davignon J, Poirier J.

Brain Res. 1999 Oct 2;843(1-2):87-94.

PMID:
10528114
[PubMed - indexed for MEDLINE]
12.

A 3'-UTR polymorphism in the oxidized LDL receptor 1 gene increases Abeta40 load as cerebral amyloid angiopathy in Alzheimer's disease.

Shi J, Tian J, Pritchard A, Lendon C, Lambert JC, Iwatsubo T, Mann DM.

Acta Neuropathol. 2006 Jan;111(1):15-20. Epub 2005 Nov 22.

PMID:
16328515
[PubMed - indexed for MEDLINE]
13.

Systemic treatment with liver X receptor agonists raises apolipoprotein E, cholesterol, and amyloid-β peptides in the cerebral spinal fluid of rats.

Suon S, Zhao J, Villarreal SA, Anumula N, Liu M, Carangia LM, Renger JJ, Zerbinatti CV.

Mol Neurodegener. 2010 Oct 29;5:44. doi: 10.1186/1750-1326-5-44.

PMID:
21034469
[PubMed]
Free PMC Article
14.

[Expression of apolipoprotein E in Alzheimer's disease and its significance].

He SR, Liu DG, Wang S, Xia YJ.

Zhonghua Bing Li Xue Za Zhi. 2005 Sep;34(9):556-60. Chinese.

PMID:
16468304
[PubMed - indexed for MEDLINE]
15.

Changes in apolipoprotein E expression in response to dietary and pharmacological modulation of cholesterol.

Petanceska SS, DeRosa S, Sharma A, Diaz N, Duff K, Tint SG, Refolo LM, Pappolla M.

J Mol Neurosci. 2003;20(3):395-406.

PMID:
14501024
[PubMed - indexed for MEDLINE]
16.

Cerebrospinal fluid beta-amyloid1-42 and tau in control subjects at risk for Alzheimer's disease: the effect of APOE epsilon4 allele.

Sunderland T, Mirza N, Putnam KT, Linker G, Bhupali D, Durham R, Soares H, Kimmel L, Friedman D, Bergeson J, Csako G, Levy JA, Bartko JJ, Cohen RM.

Biol Psychiatry. 2004 Nov 1;56(9):670-6.

PMID:
15522251
[PubMed - indexed for MEDLINE]
17.

The -491AA polymorphism in the APOE gene is associated with increased plasma apoE levels in Alzheimer's disease.

Laws SM, Taddei K, Martins G, Paton A, Fisher C, Clarnette R, Hallmayer J, Brooks WS, Gandy SE, Martins RN.

Neuroreport. 1999 Mar 17;10(4):879-82.

PMID:
10208564
[PubMed - indexed for MEDLINE]
18.

Apolipoprotein E levels in cerebrospinal fluid and the effects of ABCA1 polymorphisms.

Wahrle SE, Shah AR, Fagan AM, Smemo S, Kauwe JS, Grupe A, Hinrichs A, Mayo K, Jiang H, Thal LJ, Goate AM, Holtzman DM.

Mol Neurodegener. 2007 Apr 12;2:7.

PMID:
17430597
[PubMed]
Free PMC Article
19.

Apolipoprotein E genotype and deposits of Abeta40 and Abeta42 in Alzheimer disease.

McNamara MJ, Gomez-Isla T, Hyman BT.

Arch Neurol. 1998 Jul;55(7):1001-4.

PMID:
9678319
[PubMed - indexed for MEDLINE]
20.

Progression from MCI to AD: predictive value of CSF Aβ42 is modified by APOE genotype.

Kester MI, Verwey NA, van Elk EJ, Blankenstein MA, Scheltens P, van der Flier WM.

Neurobiol Aging. 2011 Aug;32(8):1372-8. doi: 10.1016/j.neurobiolaging.2009.08.006. Epub 2009 Sep 11.

PMID:
19748159
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk